Is lorazepam a treatment for neuroleptic malignant syndrome?

CNS Spectrums

Volumn 5, Issue 7, 2000, Pages 54-57

  Francis, A ^a   Chandragiri, S ^a   Rizvi, S ^a   Koch, M ^a   Petrides, G ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; LORAZEPAM; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL;

EID: 0033858703     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900013407     Document Type: Article

References (26)

1. Neuroleptic malignant syndrome
2. Neuroleptic malignant syndrome
3. Neuroleptic malignant syndrome: Review of response to therapy
4. Pharmacotherapy of neuroleptic malignant syndrome
5. The treatment of neuroleptic malignant syndrome: Are dantrolene and bromocriptine useful adjuncts to supportive care?
6. Diazepam-responsive neuroleptic malignant syndrome: A diagnostic subtype?
7. Chlorpromazine-induced neuroleptic syndrome and its response to lorazepam
8. Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam
9. Benzodiazepines as treatment for neuroleptic malignant syndrome
10. Neuroleptic malignant syndrome and catatonia: One entity or two?
11. The nondichotomy between lethal catatonia and neuroleptic malignant syndrome
12. Catatonia and the neuroleptic malignant syndrome - A single entity?
13. Neuroleptic malignant syndrome: Review and analysis of 115 cases
14. A prospective analysis of 24 episodes of neuroleptic malignant syndrome
15. Neuroleptic malignant syndrome
16. Management of acute extrapyramidal effects induced by antipsychotic drugs
17. Catatonic signs in neuroleptic malignant syndrome
18. Advances in the diagnosis and treatment of catatonia
19. Catatonia: A new indication for benzodiazepines?
20. Catatonic syndrome in a general psychiatric population: Frequency, clinical presentation, and response to lorazepam
21. Intravenous lorazepam in neuroleptic-induced catatonia
22. The neuroleptic malignant syndrome
23. Neuroleptic malignant syndrome
24. The neuroleptic malignant syndrome: Agent and host interaction